Multiple 340B provider groups have applauded the federal government for threatening “strong” enforcement actions that led Johnson & Johnson (J&J) [...] …
Category: Trade Association
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract [...] …
Two major hospital advocacy groups are urging the federal agency that oversees the 340B program to “take immediate enforcement action” [...] …
In a move that would fundamentally alter the 340B program, pharmaceutical giant Johnson & Johnson (J&J) told hospitals this morning [...] …
Trade groups representing pharmacists and 340B health systems have jointly released model state legislation that would prohibit drugmaker 340B contract [...] …
Two weeks after publishing an opinion piece that called for increased 340B program oversight and provider transparency, JAMA issued a [...] …
An industry-funded conservative policy group known for delivering model bills to Republican lawmakers recently urged an audience of state legislators [...] …
The upcoming U.S. presidential and congressional elections will significantly alter the direction of 340B and broader healthcare policy, a 340B [...] …
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...] …